Metal radionuclides are widely used in diagnostic imaging. Radioisotopes of gallium, indium, technetium and copper are used in nuclear medicine studies while gadolinium chelates act as paramagnetic contrast agents in conjunction with nuclear magnetic resonance imaging (MRI). New improved chelating agents for these metal ions have been designed. The properties of these new chelating agents will be predicted utilizing molecular mechanic calculations, the ligands will be synthesized and the characteristics of the metal complexes studied by physicochemical methods as well as in vivo and in vitro biological evaluation. Chelates have been designed for maximum thermadynamic stability by using ligands with donor groups highly selective for the particular metals. The charge and lipophilicity of the chelates will be altered by changing the donor groups as well as the addition of alkyl groups and other substituents. The metal chelates will be functionalized with several types of linkages to allow covalent attachment to proteins and peptides. Particular emphasis is being given to new ligands for the metal indium and copper. The stability constants of the new ligands will be determined and the kinetics of metal dissociation measured. The biological behavior of both the ligands and bifunctional chelates attached to proteins and peptides will be determined in vitro and in animal models. The synthesis characterization and physicochemical studies will be carried out at Texas A&M University while the in vitro and in vivo evaluation of the pharmaceutical preparations will be undertaken at Washington University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042925-11
Application #
2654019
Study Section
Diagnostic Radiology Study Section (RNM)
Program Officer
Menkens, Anne E
Project Start
1986-07-01
Project End
2002-01-31
Budget Start
1998-02-01
Budget End
1999-01-31
Support Year
11
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Sun, Xiankai; Kim, Joonyoung; Martell, Arthur E et al. (2004) In vivo evaluation of copper-64-labeled monooxo-tetraazamacrocyclic ligands. Nucl Med Biol 31:1051-9
Sun, Xiankai; Wuest, Melinda; Kovacs, Zoltan et al. (2003) In vivo behavior of copper-64-labeled methanephosphonate tetraaza macrocyclic ligands. J Biol Inorg Chem 8:217-25
Sun, Xiankai; Wuest, Melinda; Weisman, Gary R et al. (2002) Radiolabeling and in vivo behavior of copper-64-labeled cross-bridged cyclam ligands. J Med Chem 45:469-77
Reichert, D E; Norrby, P O; Welch, M J (2001) Molecular modeling of bifunctional chelate peptide conjugates. 1. Copper and indium parameters for the AMBER force field. Inorg Chem 40:5223-30
Sun, Y; Martell, A E; Reibenspies, J H et al. (2000) Synthesis and characterization of racemic mixture and meso isomers of bis(trans-2-aminocyclohexyl)aminepentaacetic acid and the stabilities of their Gd(III) complexes. Inorg Chem 39:1480-6
Cutler, C S; Wuest, M; Anderson, C J et al. (2000) Labeling and in vivo evaluation of novel copper(II) dioxotetraazamacrocyclic complexes. Nucl Med Biol 27:375-80
Deal, K A; Cristel, M E; Welch, M J (1998) Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver. Nucl Med Biol 25:379-85
Jones-Wilson, T M; Deal, K A; Anderson, C J et al. (1998) The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol 25:523-30
Deal, K A; Welch, M J (1997) Effect of stereochemistry on the clearance mechanism of 111In(III)-labeled D- or L-benzyldiethylenetriaminepentaacetic acid. J Med Chem 40:3986-9
Sun, Y; Anderson, C J; Pajeau, T S et al. (1996) Indium (III) and gallium (III) complexes of bis(aminoethanethiol) ligands with different denticities: stabilities, molecular modeling, and in vivo behavior. J Med Chem 39:458-70

Showing the most recent 10 out of 28 publications